A. Neil Howell
Corporate Officer/Principal en University of Texas Medical Branch .
Cargos activos de A. Neil Howell
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| University of Texas Medical Branch | Corporate Officer/Principal | - | - |
Historial de carrera de A. Neil Howell
Antiguos cargos conocidos de A. Neil Howell.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Director Técnico/Científico/I+D | 01/08/2004 | - |
MitoKor, Inc.
 MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA | Director Técnico/Científico/I+D | 01/01/2000 | - |
Formación de A. Neil Howell.
| University of Kansas | Undergraduate Degree |
| University of Wisconsin | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Canadá | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Consumer Services | 4 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
MitoKor, Inc.
MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA | Health Technology |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- A. Neil Howell
- Experiencia
